Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Primary nitrate tolerance in diabetes mellitus

Primary nitrate tolerance in diabetes mellitus Diabetologia (1994) 37:115-117 Diabetologia 9 Springer-Verlag 1994 For debate G . M c V e i g h 1, G . B r e n n a n 2, R . H a y e s 3, D . J o h n s t o n 2 1 Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA 2 Department of Therapeutics and Pharmacology, Belfast City Hospital, Belfast, Northern Ireland 3 Department of Medicine, Belfast City Hospital, Belfast, Northern Ireland First synthesised in 1846, glyceryl trinitrate was employed clinically as early as 1879 to treat angina pectoris. Today organic nitrates remain a cornerstone in the treatment of chronic stable and unstable angina, acute myocardial infarction, and acute and chronic congestive cardiac failure. The drugs act to produce smooth muscle relaxation that results in dilation of veins, arteries and arterioles. Venodilation that results in pooling of blood in the capacitance vessels occurs at very low plasma concentrations, while arteriolar dilation resulting in a fall in blood pressure and systemic resistance require larger doses of nitrates. The reduction in cardiac preload and afterload decreases myocardial oxygen demand and serves as the main mechanism by which nitrates relieve angina and myocardial http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Diabetologia Springer Journals

Primary nitrate tolerance in diabetes mellitus

Diabetologia , Volume 37 (1) – Jan 1, 1994

Loading next page...
 
/lp/springer-journals/primary-nitrate-tolerance-in-diabetes-mellitus-U6vY35Dx2z

References (12)

Publisher
Springer Journals
Copyright
Copyright © 1994 by Springer-Verlag
Subject
Medicine & Public Health; Human Physiology; Internal Medicine; Metabolic Diseases
ISSN
0012-186X
eISSN
1432-0428
DOI
10.1007/BF00428787
Publisher site
See Article on Publisher Site

Abstract

Diabetologia (1994) 37:115-117 Diabetologia 9 Springer-Verlag 1994 For debate G . M c V e i g h 1, G . B r e n n a n 2, R . H a y e s 3, D . J o h n s t o n 2 1 Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA 2 Department of Therapeutics and Pharmacology, Belfast City Hospital, Belfast, Northern Ireland 3 Department of Medicine, Belfast City Hospital, Belfast, Northern Ireland First synthesised in 1846, glyceryl trinitrate was employed clinically as early as 1879 to treat angina pectoris. Today organic nitrates remain a cornerstone in the treatment of chronic stable and unstable angina, acute myocardial infarction, and acute and chronic congestive cardiac failure. The drugs act to produce smooth muscle relaxation that results in dilation of veins, arteries and arterioles. Venodilation that results in pooling of blood in the capacitance vessels occurs at very low plasma concentrations, while arteriolar dilation resulting in a fall in blood pressure and systemic resistance require larger doses of nitrates. The reduction in cardiac preload and afterload decreases myocardial oxygen demand and serves as the main mechanism by which nitrates relieve angina and myocardial

Journal

DiabetologiaSpringer Journals

Published: Jan 1, 1994

There are no references for this article.